GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Hainan Shuangcheng Pharmaceuticals Co Ltd (SZSE:002693) » Definitions » EV-to-FCF

Hainan Shuangcheng Pharmaceuticals Co (SZSE:002693) EV-to-FCF : -50.83 (As of Jun. 04, 2024)


View and export this data going back to 2012. Start your Free Trial

What is Hainan Shuangcheng Pharmaceuticals Co EV-to-FCF?

EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Hainan Shuangcheng Pharmaceuticals Co's Enterprise Value is ¥2,169.6 Mil. Hainan Shuangcheng Pharmaceuticals Co's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2024 was ¥-42.7 Mil. Therefore, Hainan Shuangcheng Pharmaceuticals Co's EV-to-FCF for today is -50.83.

The historical rank and industry rank for Hainan Shuangcheng Pharmaceuticals Co's EV-to-FCF or its related term are showing as below:

SZSE:002693' s EV-to-FCF Range Over the Past 10 Years
Min: -459.1   Med: -33.94   Max: 573.53
Current: -53.56

During the past 13 years, the highest EV-to-FCF of Hainan Shuangcheng Pharmaceuticals Co was 573.53. The lowest was -459.10. And the median was -33.94.

SZSE:002693's EV-to-FCF is ranked worse than
100% of 532 companies
in the Drug Manufacturers industry
Industry Median: 22.76 vs SZSE:002693: -53.56

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-06-04), Hainan Shuangcheng Pharmaceuticals Co's stock price is ¥4.79. Hainan Shuangcheng Pharmaceuticals Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 was ¥-0.152. Therefore, Hainan Shuangcheng Pharmaceuticals Co's PE Ratio for today is At Loss.


Hainan Shuangcheng Pharmaceuticals Co EV-to-FCF Historical Data

The historical data trend for Hainan Shuangcheng Pharmaceuticals Co's EV-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hainan Shuangcheng Pharmaceuticals Co EV-to-FCF Chart

Hainan Shuangcheng Pharmaceuticals Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only 138.69 -31.92 -262.19 -404.61 -87.57

Hainan Shuangcheng Pharmaceuticals Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
EV-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -256.89 -106.98 -91.93 -87.57 -64.87

Competitive Comparison of Hainan Shuangcheng Pharmaceuticals Co's EV-to-FCF

For the Drug Manufacturers - Specialty & Generic subindustry, Hainan Shuangcheng Pharmaceuticals Co's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Hainan Shuangcheng Pharmaceuticals Co's EV-to-FCF Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Hainan Shuangcheng Pharmaceuticals Co's EV-to-FCF distribution charts can be found below:

* The bar in red indicates where Hainan Shuangcheng Pharmaceuticals Co's EV-to-FCF falls into.



Hainan Shuangcheng Pharmaceuticals Co EV-to-FCF Calculation

Hainan Shuangcheng Pharmaceuticals Co's EV-to-FCF for today is calculated as:

EV-to-FCF=Enterprise Value (Today)/Free Cash Flow (TTM)
=2169.556/-42.685
=-50.83

Hainan Shuangcheng Pharmaceuticals Co's current Enterprise Value is ¥2,169.6 Mil.
Hainan Shuangcheng Pharmaceuticals Co's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥-42.7 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Hainan Shuangcheng Pharmaceuticals Co  (SZSE:002693) EV-to-FCF Explanation

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

Hainan Shuangcheng Pharmaceuticals Co's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=4.79/-0.152
=At Loss

Hainan Shuangcheng Pharmaceuticals Co's share price for today is ¥4.79.
Hainan Shuangcheng Pharmaceuticals Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥-0.152.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.


Hainan Shuangcheng Pharmaceuticals Co EV-to-FCF Related Terms

Thank you for viewing the detailed overview of Hainan Shuangcheng Pharmaceuticals Co's EV-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Hainan Shuangcheng Pharmaceuticals Co (SZSE:002693) Business Description

Traded in Other Exchanges
N/A
Address
16 Xingguo Road, Xiuying District, Haikou, CHN, 570311
Hainan Shuangcheng Pharmaceuticals Co Ltd is engaged in the research, development, and sales of synthesized peptide drugs.
Executives
Yuan Jian Lin Executives
Zhang Wei Executives
Yu Xiao Feng Directors, executives
Wang Xu Guang Executives
Directors, executives
Wang Cheng Dong Directors, executives
Executives
Hu Yi Securities Affairs Representative

Hainan Shuangcheng Pharmaceuticals Co (SZSE:002693) Headlines

No Headlines